|
1
|
van den Bent MJ, Geurts M, French PJ,
Smits M, Capper D, Bromberg JEC and Chang SM: Primary brain tumours
in adults. Lancet. 402:1564–1579. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weller M, Wen PY, Chang SM, Dirven L, Lim
M, Monje M and Reifenberger G: Glioma. Nat Rev Dis Primers.
10:332024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chai X, Zhang Y, Zhang W, Feng K, Jiang Y,
Zhu A, Chen X, Di L and Wang R: Tumor metabolism: A new field for
the treatment of glioma. Bioconjug Chem. 35:1116–1141. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Obrador E, Moreno-Murciano P,
Oriol-Caballo M, López-Blanch R, Pineda B, Gutiérrez-Arroyo JL,
Loras A, Gonzalez-Bonet LG, Martinez-Cadenas C, Estrela JM and
Marqués-Torrejón MÁ: Glioblastoma therapy: Past, present and
future. Int J Mol Sci. 25:25292024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mishchenko TA, Turubanova VD, Gorshkova
EN, Krysko O, Vedunova MV and Krysko DV: Glioma: Bridging the tumor
microenvironment, patient immune profiles and novel personalized
immunotherapy. Front Immunol. 14:12990642023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weiskirchen R and Günther K: The
CRP/MLP/TLP family of LIM domain proteins: Acting by connecting.
BioEssays. 25:152–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schallus T, Fehér K, Ulrich AS, Stier G
and Muhle-Goll C: Structure and dynamics of the human muscle LIM
protein. FEBS Lett. 583:1017–1022. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang DF, Belaguli NS, Chang J and
Schwartz RJ: LIM-only protein, CRP2, switched on smooth muscle gene
activity in adult cardiac myocytes. Proc Natl Acad Sci U S A.
104:157–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Guan X, Zhang Y, Ge S, Zhang L, Li
H, Wang X, Liu R, Ning T, Deng T, et al: Exosomal miR-27a derived
from gastric cancer cells regulates the transformation of
fibroblasts into cancer-associated fibroblasts. Cell Physiol
Biochem. 49:869–883. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen CH, Ho YC, Ho HH, Chang IC, Kirsch
KH, Chuang YJ, Layne MD and Yet SF: Cysteine-rich protein 2 alters
p130Cas localization and inhibits vascular smooth muscle cell
migration. Cardiovasc Res. 100:461–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu ML, Chen CH, Lin YT, Jheng YJ, Ho YC,
Yang LT, Chen L, Layne MD and Yet SF: Divergent signaling pathways
cooperatively regulate TGFbeta induction of cysteine-rich protein 2
in vascular smooth muscle cells. Cell Commun Signal. 12:222014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoffmann C, Mao X, Brown-Clay J, Moreau F,
Al Absi A, Wurzer H, Sousa B, Schmitt F, Berchem G, Janji B and
Thomas C: Hypoxia promotes breast cancer cell invasion through
HIF-1alpha-mediated up-regulation of the invadopodial actin
bundling protein CSRP2. Sci Rep. 8:101912018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang MJ, Liu J, Wan SC, Li JX, Wang S,
Fidele NB, Huang CF and Sun ZJ: CSRP2 promotes cell stemness in
head and neck squamous cell carcinoma. Head Neck. 45:2161–2172.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Long X, Duan S, Liu X, Chen J, Lan
J, Liu X, Huang W, Geng J and Zhou J: CSRP2 suppresses colorectal
cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and
HIPPO signaling pathways. Theranostics. 10:11063–11079. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang J: Current developments of targeting
the p53 signaling pathway for cancer treatment. Pharmacol Ther.
220:1077202021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weiskirchen R, Moser M, Weiskirchen S,
Erdel M, Dahmen S, Buettner R and Gressner AM: LIM-domain protein
cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of
hepatic stellate cells and binding partner of the protein inhibitor
of activated STAT1. Biochem J. 359:485–496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Śledzińska P, Bebyn MG, Furtak J,
Kowalewski J and Lewandowska MA: Prognostic and predictive
biomarkers in gliomas. Int J Mol Sci. 22:103732021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong X, Tang R, Xiao M, Xu J, Wang W,
Zhang B, Liu J, Yu X and Shi S: Targeting cell death pathways for
cancer therapy: Recent developments in necroptosis, pyroptosis,
ferroptosis, and cuproptosis research. J Hematol Oncol. 15:1742022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang FY, Dai SZ, Xu WT, Xiong W, Sun Y,
Huang YH, Wang JY, Lin YY, Chen H, Tan GH and Zheng WP:
3′-epi-12beta-hydroxyfroside-mediated autophagy degradation of
RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in
triple-negative breast cancer cells. Pharmacol Res. 187:1066132023.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pomlok K, Pata S, Kulaphisit M, Pangnuchar
R, Wipasa J, Smith DR, Kasinrerk W and Lithanatudom P: An IgM
monoclonal antibody against domain 1 of CD147 induces non-canonical
RIPK-independent necroptosis in a cell type specific manner in
hepatocellular carcinoma cells. Biochim Biophys Acta Mol Cell Res.
1869:1192952022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vetrivel P, Nachimuthu S, Abuyaseer A,
Bhosale PB, Ha SE, Kim HH, Park MY and Kim GS: Investigation on the
cellular mechanism of prunetin evidenced through next generation
sequencing and bioinformatic approaches against gastric cancer. Sci
Rep. 12:118522022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang HL, Chang JC, Fang LW, Hsu HF, Lee
LC, Yang JF, Liang MT, Hsiao PC, Wang CP, Wang SW, et al: Bulnesia
sarmientoi supercritical fluid extract exhibits necroptotic effects
and anti-metastatic activity on lung cancer cells. Molecules.
23:33042018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu B, Mink S, Wong KA, Stein N, Getman C,
Dempsey PW, Wu H and Shuai K: PIAS1 selectively inhibits
interferon-inducible genes and is important in innate immunity. Nat
Immunol. 5:891–898. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q,
Bao Z, Lu J and Li L: Evolving cognition of the JAK-STAT signaling
pathway: Autoimmune disorders and cancer. Signal Transduct Target
Ther. 8:2042023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Fang ZM, Yi X, Wei X and Jiang DS:
The interaction between ferroptosis and inflammatory signaling
pathways. Cell Death Dis. 14:2052023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vier J, Groth M, Sochalska M and Kirschnek
S: The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates
neutrophil survival and homeostasis and is controlled via PI3K and
JAK/STAT signaling. Cell Death Dis. 7:e21032016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu X, Ma H, Li B, Ji Y, Du Y, Liu S, Li Z,
Hao Y, Tian S, Zhao C, et al: A novel RIPK1 inhibitor reduces GVHD
in mice via a nonimmunosuppressive mechanism that restores
intestinal homeostasis. Blood. 141:1070–1086. 2023. View Article : Google Scholar : PubMed/NCBI
|
